Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
1026
-
Total 13F shares, excl. options
-
123M
-
Shares change
-
-1.83M
-
Total reported value, excl. options
-
$34.9B
-
Value change
-
-$615M
-
Put/Call ratio
-
1.39
-
Number of buys
-
409
-
Number of sells
-
-511
-
Price
-
$282.99
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q3 2021
1,222 filings reported holding BIIB - BIOGEN INC. - COM as of Q3 2021.
BIOGEN INC. - COM (BIIB) has 1,026 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
of 147M outstanding shares and own 84.21% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (16.3M shares), BlackRock Inc. (13.9M shares), VANGUARD GROUP INC (11.7M shares), STATE STREET CORP (6.9M shares), JPMORGAN CHASE & CO (5.61M shares), WELLINGTON MANAGEMENT GROUP LLP (5.58M shares), Clearbridge Investments, LLC (3.36M shares), GEODE CAPITAL MANAGEMENT, LLC (2.78M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.78M shares), and NORTHERN TRUST CORP (1.76M shares).
This table shows the top 1026 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.